Device maker Teleflex boosts urology business with NeoTract buy
Teleflex Inc buys NeoTract Inc to strengthen its portfolio of urology devices. The deal’s value could rise to $1.1B based on sales of NeoTract’s UroLift System.
The deal is Teleflex’s 23rd since 2008 and comes after its $1B acquisition of Vascular Solutions in December for its minimally invasive coronary and vascular devices. Teleflex will pay NeoTract $725M when the deal closes and an additional $375M when it hits certain sales milestones through 2020.
